Authorship contributions
Karan Seegobin: Have made substantial contributions to
conception and design, acquisition of data, and drafting the manuscript.
Muhamad Alhaj Moustafa: Have made substantial contributions to
acquisition of data and drafting the manuscript.
Deborah Fischer: Have made substantial contributions to
conception and design, acquisition of data, and drafting the manuscript.
Katelyn Keller: Have made substantial contributions to
conception and design, acquisition of data, and drafting the manuscript.
Jacquelyn Hastings: Have made substantial
contributions to conception and design, acquisition of data, and
drafting the manuscript.
Mohamed A. Kharfan-Dabaja: Have made substantial contributions
to conception and design, and revising it critically for important
intellectual content.
Ernesto Ayala: Have made substantial contributions to
conception and design, and revising it critically for important
intellectual content.
Han W Tun: Have made substantial contributions to conception
and design, and revising it critically for important intellectual
content.
Liuyan Jiang: Have made substantial contributions to conception
and design, and revising it critically for important intellectual
content.
Conflict of interest
Mohamed A. Kharfan-Dabaja: reports consultancy for Pharmacyclics and
Daiichi Sankyo
All other authors have no conflict of interest to declare
References
- Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis:
International Primary CNS Lymphoma Collaborative Group report.
International Primary CNS Lymphoma Collaborative Group Report. Blood.
2010; 115:5005-11.
- Baehring JM, Damek D, Martin EC, et al. Neurolymphomatosis. Neuro
Oncol. 2003; 5:104-115.
- Novo M, Nowakowski GS, Micallef IN, et al. Clinical features,
treatment and outcome of neurolymphomatosis: single institution
experience. Hematological Oncology 2019.
https://doi.org/10.1002/hon.80_2630
- Levin N, Soffer D, Grissaru S, et al. Primary T-cell CNS lymphoma
presenting with leptomeningeal spread and neurolymphomatosis. J
Neurooncol. 2008; 90:77-83.
- Wang CX, Wang H, Li J, et al. Brain metastasis of ALK positive
anaplastic large cell lymphoma after a long-term disease-free survival
in an old adult. Int J Clin Exp Pathol . 2014; 7:1182–1187.
- Chihara D, Fanale MA, Miranda RN, et al. The risk of central nervous
system relapses in patients with peripheral T-cell lymphoma.PLoS One . 2018; 13: e0191461.
- Kuntegowdenahalli LC, Jacob LA, Komaranchath AS, Amirtham U. A rare
case of primary anaplastic large cell lymphoma of the central nervous
system. J Cancer Res Ther. 2015; 11:943-5.
- Gurion R, Mehta N, Migliacci JC, et al. Central nervous system
involvement in T-cell lymphoma: A single center experience. Acta
Oncol . 2016; 55:561–566.
- Shenkier TN, Blay JY, O’Neill BP, et al. Primary CNS Lymphoma of
T-Cell Origin: A Descriptive Analysis From the International Primary
CNS Lymphoma Collaborative Group. J Clin Oncol 2005;23:2233-2239
Figure1. MRI brain axial and sagittal sections show bilateral nodular
leptomeningeal enhancements in the posterior fossa and enhancement
around both optic nerves (Before treatment). MRI after 2 cycles show no
radiological evidence of residual lymphoma (After treatment).